logo
  

UK Successfully Tests Quantum Navigation In Flight

navigationinflight may13 lt

In the world's first-of-its-kind commercial achievement, the UK has successfully completed commercial flight trials of advanced quantum-based navigation systems that cannot be jammed or spoofed by hostile actors.

While GPS jamming is currently relatively rare and does not directly impact an aircraft's flight path, quantum systems will provide another layer of security by providing highly accurate and resilient navigation that complements current satellite systems.

This new quantum-based Positioning, Navigation, and Timing (PNT) systems could help ensure that the thousands of flights that take place around the world daily, proceed without disruption.

Quantum technology firm Infleqtion, in collaboration with aerospace companies BAE Systems and QinetiQ, completed the trials at MoD Boscombe Down in Wiltshire.

Science Minister Andrew Griffith was aboard the final test flight, the UK Department for Science, Innovation and Technology said in a press release.

This is the first time that this sort of ground-breaking technology has been tested in the UK on an aircraft in flight, and the first such flights worldwide that have been publicly acknowledged, according to it.

Led by Infleqtion and in collaboration with industry and academic partners, this project has received nearly 8 million pounds ($10 million) from the government. This funding, together with the 2.5 billion pound ($3.13 million) National Quantum Strategy and the National Quantum Technologies Programme, aims to cement the UK's position as a leading quantum-enabled economy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Microsoft has launched a new category of Windows PCs designed for Artificial Intelligence (AI) that are slated to be the fastest and most intelligent Windows PCs ever built. The Copilot+ PCs come with built-in AI hardware and will support AI features across the operating system. Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, according to the U.S. Food and Drug Administration. The recall was initiated due to the potential for incomplete crimp seals. The company has received one customer complaint for one leaking unit. While reporting financial results for the first quarter on Wednesday, off-price retailer TJX Companies, Inc. (TJX) provided its earnings and comparable store sales outlook for the second quarter and raised earnings outlook for the full-year 2024. For the second quarter, the company now expects earnings...

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
Follow RTT